A recent survey of uninsured Americans by Oliver Wyman shows they are eager for new healthcare products and services, but don't understand their options.
A recent survey of uninsured Americans by Oliver Wyman shows they are eager for new healthcare products and services, but don’t understand their options. It illustrates the importance of new products and consumer education efforts.
According to the survey of about 800 uninsured consumers likely to purchase coverage in the under-65 healthcare exchanges, 76% elected to purchase coverage rather than pay a penalty. Oliver Wyman estimates there are 51 million uninsured Americans, and about 18 million would not need to purchase insurance for themselves because they are below the Poverty Level cutoff. If the survey ratio holds true, that 76% would represent 25 million newly insured Americans.
“The opening of the exchanges is just the first step in changing U.S. healthcare from wholesale to retail,” says Helen Leis, Oliver Wyman partner in the Health & Life Sciences Practice. “By 2020, as employers opt out of health insurance or move to defined contribution programs, we expect that something like 100 million people will be making individual decisions about health insurance. To me, the survey shows that they are likely to display more variety and have more specific needs and wants than many health plans are anticipating.”
In the study, participants were offered a series of $50-a-month upgrades to coverage or service, as well as scenarios in which consumers would receive a $50-a-month discount for agreeing to change how they accessed the healthcare system or for embracing healthy lifestyle choices. According to the survey:
41% were willing to receive a majority of their medical care at a retail clinic located in a pharmacy or retail store
52% were willing to reach a healthy body weight
38% of those who smoked were willing to quit
48% were willing to interact with their doctor primarily online.
38% were willing to pay extra for 24-hour-a-day, seven-day-a-week access to doctors
26% would pay for coverage and access to alternative medicine.
While the study also found uninsured Americans are extremely cost-sensitive, Leis says there is reason for optimism that the exchanges could become laboratories for healthcare innovation.
“The real opportunity for health plans is to start creating value by solving the innumerable hassles consumers face in navigating the healthcare system,” she says. “If you think of what the Kindle did for books or the iPod for music, the grail for health plans is something that does the same thing for healthcare - making the system transparent, efficient, and integrated.”
The full report can be downloaded here: http://www.oliverwyman.com/insidetheuninsured.
FDA Approves Amvuttra for ATTR-CM in Extended Label
March 21st 2025This expanded indication for Amvuttra makes it the first and only FDA-approved treatment for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
March 20th 2025Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells genetically engineered to produce specific therapeutic proteins. It will be available in June 2025.
Read More